Small Cell Lung Carcinoma Expressing Dll3 clinical trials

Explore recruiting small cell lung carcinoma expressing dll3 clinical trials.

Recruiting small cell lung carcinoma expressing dll3 studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Small Cell Lung Carcinoma Expressing Dll3 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A study to test different doses of obrixtamig (BI 764532) combined with ezabenlimab in patients with Small Cell Lung Carcinoma and other neuroendocrine neoplasms expressing DLL3

Belgium, France, Germany

Human Pharmacology (Phase I)- Other EU CTIS Study details

Small Cell Lung Carcinoma Expressing Dll3 trials by city

Small Cell Lung Carcinoma Expressing Dll3 in Toronto Small Cell Lung Carcinoma Expressing Dll3 in Vancouver Small Cell Lung Carcinoma Expressing Dll3 in Montreal Small Cell Lung Carcinoma Expressing Dll3 in Calgary Small Cell Lung Carcinoma Expressing Dll3 in Edmonton Small Cell Lung Carcinoma Expressing Dll3 in Ottawa Small Cell Lung Carcinoma Expressing Dll3 in Winnipeg Small Cell Lung Carcinoma Expressing Dll3 in Quebec City Small Cell Lung Carcinoma Expressing Dll3 in Hamilton Small Cell Lung Carcinoma Expressing Dll3 in Kitchener Small Cell Lung Carcinoma Expressing Dll3 in London Small Cell Lung Carcinoma Expressing Dll3 in Halifax Small Cell Lung Carcinoma Expressing Dll3 in New York Small Cell Lung Carcinoma Expressing Dll3 in Los Angeles Small Cell Lung Carcinoma Expressing Dll3 in Chicago Small Cell Lung Carcinoma Expressing Dll3 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease